ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,878Medicare Part D Prescriptions Filled, Including Refills
$159K Total Retail Price of All Prescriptions
411 Patients Receiving at Least One Drug in Part D
91%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume .

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category
HYDROCODONE-ACETAMINOPHEN 287 261 S3
OMEPRAZOLE 263 213
FUROSEMIDE 250 213
LEVOTHYROXINE SODIUM 243 192
LISINOPRIL 212 176
METOPROLOL TARTRATE 212 185
POTASSIUM CHLORIDE 201 182
VITAMIN D2 200 152
AMLODIPINE BESYLATE 172 153
NAMENDA 164 156
DONEPEZIL HCL 158 154
SIMVASTATIN 148 120
WARFARIN SODIUM 142 120
CITALOPRAM HBR 129 121
SERTRALINE HCL 121 103
TRAMADOL HCL 117 100
METFORMIN HCL 111 87
TRAZODONE HCL 108 84
ZOLPIDEM TARTRATE 100 95
GABAPENTIN 90 61
METOPROLOL SUCCINATE 89 87
ALPRAZOLAM 83 70
MIRTAZAPINE 79 77
CARVEDILOL 74 56
DIVALPROEX SODIUM 68 46
LORAZEPAM 67 51
RISPERIDONE 61 58
ATORVASTATIN CALCIUM 60 40
ADVAIR DISKUS 59 49
ISOSORBIDE MONONITRATE ER 58 53
LANTUS 57 29
HYDROCHLOROTHIAZIDE 56 49
ALENDRONATE SODIUM 53 47
FLUTICASONE PROPIONATE 53 34
DIGOXIN 52 44
LOSARTAN POTASSIUM 52 43
SPIRONOLACTONE 51 44
LOSARTAN-HYDROCHLOROTHIAZIDE 50 49
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.